体外膜肺氧合作为肺移植桥接的当代结局
2012至2015年,30例患者接受体外膜肺氧合(ECMO)作为肺移植桥接(BTT),首选双腔单套管者13例(43%)。26例(87%)桥接成功,30天、1年、3年生存率分别为92%、85%、80%。作者认为严格选择患者并早期使用ECMO似乎可在等待供器官期间保持体能,或可改善结局。
要点
- 30例ECMO桥接肺移植患者中26例(87%)桥接成功,围术期结局与早期生存令人鼓舞。
- 全部移植患者30天、1年、3年生存率分别为92%、85%、80%;首次移植者3年生存率91%。
- 19例双腔单套管患者中5例(26%)成功步行、6例(32%)实现自主通气。
核心结论
- ECMO作为肺移植桥接带来了令人鼓舞的围术期结局和早期生存;严格的患者选择与早期使用ECMO似乎可在危重候选者等待供器官期间保持体能,或可改善结局。
研究设计与样本
- 2012年至2015年,30例患者接受ECMO作为肺移植桥接;ECMO适合性在移植名单登记前确定。
主要发现
- 30例中13例(43%)首选双腔单套管;其余患者中6例(20%)使用静脉-动脉ECMO、11例(37%)使用静脉-静脉ECMO,11例(37%)采用双部位置管,其中6例转为双腔单套管。
- BTT在26例(87%)中成功;19例双腔单套管患者中5例(26%)成功步行、6例(32%)实现自主通气。
- 重症监护室与住院时间中位数(第25、75百分位)分别为33天(20、46天)和56天(28、78天);成功步行者分别为20天和31天(重症监护室p=0.5;住院p=0.4)。
- 全部接受移植患者30天、1年、3年生存率分别为92%、85%、80%;首次移植患者3年生存率为91%。
临床怎么用
- 所有ECMO患者均在专设的心/肺衰竭重症监护室管理,强调早期积极物理治疗、步行和自主呼吸试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extracorporeal membrane oxygenation (ECMO), when used as bridge to lung transplantation, (BTT) identifies high-risk candidates. Recent advances in cannula design and patient selection fosters "awake ambulatory ECMO" as a viable option for critically ill candidates in an attempt to retard deconditioning while awaiting allografts. METHODS: From 2012 to 2015, 30 patients underwent ECMO as BTT. Candidacy for ECMO was determined before listing for transplant. A dual-lumen single cannula was used first in 13 of 30 patients (43%). Of the remaining 30 patients, 6 (20%) were supported with venoarterial ECMO and 11 (37%) with venovenous ECMO, with double-site cannulation in 11 (37%), and 6 of 11 converted to a dual-lumen single cannula. All ECMO patients were managed in a dedicated heart/lung failure intensive care unit, and early aggressive physical therapy, ambulation, and spontaneous breathing trials were emphasized. RESULTS: BTT was successful in 26 patients (87%). In the 19 patients with dual-lumen single cannula, 5 (26%) were successfully ambulated, and 6 (32%) achieved spontaneous ventilation. Median (25th, 75th percentile) lengths of stay in the intensive care unit and hospital were 33 days (20, 46 days) and 56 days (28, 78 days), respectively, and were 20 and 31 days, respectively, in patients successfully ambulated (intensive care unit: p = 0.5; hospital: p = 0.4). Among all patients who received a transplant, 30-day, 1-year, and 3-year survival were 92%, 85%, and 80%, respectively. Among patients undergoing primary transplants, 3-year survival was 91%. CONCLUSIONS: ECMO as BTT has led to encouraging perioperative outcomes and early survival. Careful patient selection and early use of ECMO seems to allow for preservation of vitality while these critically ill candidates await donor organs, which may improve outcomes.
引用
- Hakim AH, Ahmad U, McCurry KR, et al. Contemporary Outcomes of Extracorporeal Membrane Oxygenation Used as Bridge to Lung Transplantation. Ann Thorac Surg. 2018. PMID: 29559375. doi:10.1016/j.athoracsur.2018.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。